Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Sodium Salicylate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 5Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 54-21-7, Sodium 2-hydroxybenzoate, Enterosalicyl, Kerasalicyl, Clin, Alysine
    Molecular Formula
    C7H5NaO3
    Molecular Weight
    160.10  g/mol
    InChI Key
    ABBQHOQBGMUPJH-UHFFFAOYSA-M
    FDA UNII
    WIQ1H85SYP
    A non-steroidal anti-inflammatory agent that is less effective than equal doses of ASPIRIN in relieving pain and reducing fever. However, individuals who are hypersensitive to ASPIRIN may tolerate sodium salicylate. In general, this salicylate produces the same adverse reactions as ASPIRIN, but there is less occult gastrointestinal bleeding. (From AMA Drug Evaluations Annual, 1992, p120)
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    sodium;2-hydroxybenzoate
    2.1.2 InChI
    InChI=1S/C7H6O3.Na/c8-6-4-2-1-3-5(6)7(9)10;/h1-4,8H,(H,9,10);/q;+1/p-1
    2.1.3 InChI Key
    ABBQHOQBGMUPJH-UHFFFAOYSA-M
    2.1.4 Canonical SMILES
    C1=CC=C(C(=C1)C(=O)[O-])O.[Na+]
    2.2 Other Identifiers
    2.2.1 UNII
    WIQ1H85SYP
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Salicylate, Sodium

    2.3.2 Depositor-Supplied Synonyms

    1. 54-21-7

    2. Sodium 2-hydroxybenzoate

    3. Enterosalicyl

    4. Kerasalicyl

    5. Clin

    6. Alysine

    7. Salsonin

    8. Benzoic Acid, 2-hydroxy-, Monosodium Salt

    9. Enterosalil

    10. Entrosalyl

    11. Glutosalyl

    12. Magsalyl

    13. Aroall

    14. Kerosal

    15. Nadisal

    16. Salisod

    17. Idocyl Novum

    18. Neo-salicyl

    19. Natrum Salicylicum

    20. Monosodium Salicylate

    21. Salicylic Acid Sodium Salt

    22. Diuretin

    23. Parbocyl-rev

    24. Sodium;2-hydroxybenzoate

    25. Salicylate Sodium

    26. Salicylic Acid, Sodium Salt

    27. Sodium O-hydroxybenzoate

    28. Salicylic Acid Sodium

    29. Wiq1h85syp

    30. O-hydroxybenzoic Acid, Sodium Salt

    31. Chebi:9180

    32. Nsc-202167

    33. 90218-97-6

    34. Benzoic Acid, 2-hydroxy-, Monosodium Salt, Coupled With 4-amino-1-naphthalenesulfonic Acid And Diazotized 2-(4-aminophenyl)-1h-benzimidazol-5-amine, Sodium Salt

    35. Salicylic Acid Sodium Salt;2-hydroxybenzoic Acid Sodium Salt

    36. Natrium Salicylat [german]

    37. Ccris 6715

    38. Einecs 200-198-0

    39. Unii-wiq1h85syp

    40. Nsc 202167

    41. Sodium Salicylate [usp:jan]

    42. Natrii Salicylas

    43. Mfcd00002440

    44. Sodium;2-carboxyphenolate

    45. Sodium Salicylate, 99%

    46. Spectrum2_001945

    47. Spectrum3_000900

    48. Spectrum4_000995

    49. Spectrum5_001120

    50. Dsstox_cid_1708

    51. Ec 200-198-0

    52. Schembl4603

    53. Dsstox_rid_76287

    54. Dsstox_gsid_21708

    55. Kbiogr_001429

    56. 90218-94-3

    57. Spectrum1500533

    58. Spbio_002009

    59. Chembl447868

    60. Sodium Salicylate [jan]

    61. Dtxsid5021708

    62. Sodium Salicylate (jp17/usp)

    63. Sodium Salicylate [inci]

    64. Hy-b0167a

    65. Kbio3_001820

    66. Natrum Salicylicum [hpus]

    67. Sodium Salicylate [vandf]

    68. Sodium Salicylate [mart.]

    69. Hms1920p16

    70. Hms2092g17

    71. Salicylate Sodium [who-dd]

    72. Sodium Salicylate [usp-rs]

    73. Sodium Salicylate [who-ip]

    74. Sodium Salicylate, P.a., 99.5%

    75. Tox21_200411

    76. 2-hydroxy Benzoic Acid, Sodium Salt

    77. Ccg-39474

    78. Akos003051698

    79. Akos005766021

    80. Cs-2008

    81. Cas-54-21-7

    82. Natrii Salicylas [who-ip Latin]

    83. Salicylic Acid Sodium Salt [mi]

    84. Sodium Salicylate [ep Monograph]

    85. Ncgc00094780-01

    86. Ncgc00094780-02

    87. Ncgc00257965-01

    88. Sodium Salicylate [usp Monograph]

    89. Db-052516

    90. Ft-0631235

    91. C07587

    92. D00566

    93. D83111

    94. Sodium Salicylate, Reagentplus(r), >=99.5%

    95. Sodium Salicylate, Saj First Grade, >=99.5%

    96. Sodium Salicylate, Tested According To Ph.eur.

    97. Sodium Salicylate, Saj Special Grade, >=99.5%

    98. 2,4-dimethoxyphenylboronicacid,pinacolester

    99. Q414547

    100. Sodium Salicylate, Vetec(tm) Reagent Grade, 99%

    101. Sodium Salicylate, Meets Usp Testing Specifications

    102. Sodium Salicylate, Puriss. P.a., >=99.5% (nt)

    103. Sodium Salicylate, European Pharmacopoeia (ep) Reference Standard

    104. Sodium Salicylate, United States Pharmacopeia (usp) Reference Standard

    105. Benzoic Acid,2-hydroxy-,monosodium Salt,coupled With 4-amino-5-hydroxy-2,7-naphthalenedisulfonic Acid,diazotized 2-(4-aminophenyl)-1h-benzimidazol-5-amine And Diazotized 4-nitrobenzenamine,sodium

    106. Sodium Salicylate, Puriss. P.a., Reag. Ph. Eur., 99.5-101.0% (calc. To The Dried Substance)

    2.4 Create Date
    2007-11-13
    3 Chemical and Physical Properties
    Molecular Weight 160.10 g/mol
    Molecular Formula C7H5NaO3
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count3
    Rotatable Bond Count1
    Exact Mass160.01363830 g/mol
    Monoisotopic Mass160.01363830 g/mol
    Topological Polar Surface Area60.4 Ų
    Heavy Atom Count11
    Formal Charge0
    Complexity138
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Anti-Inflammatory Agents, Non-Steroidal

    Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)

    Cyclooxygenase Inhibitors

    Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)

    4.2 ATC Code

    N - Nervous system

    N02 - Analgesics

    N02B - Other analgesics and antipyretics

    N02BA - Salicylic acid and derivatives

    N02BA04 - Sodium salicylate